Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This study is a prospective clinical study to evaluate the safety and efficacy of two
different doses of Asacol for the treatment of moderately active ulcerative colitis. In
addition, a new tablet formulation will be evaluated at one of the two doses.